Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Change in the number of shares and votes in Atlas Copco AB

Nacka, Sweden, May 31, 2022: During May 2022, the number of outstanding shares in Atlas Copco AB increased from 1,229,613,104 to 6,148,065,520 and the number of votes from 878,415,996.80 to 4,392,079,984.00. The change is a result of the share split resolved by the Annual General Meeting on April 26, 2022, whereby each existing share was split in four (4) ordinary shares and one (1) redemption share. The redemption shares will be automatically redeemed, and the number of outstanding shares will decrease accordingly.Following the split, there were 4,196,970,480 series A shares in the company

The European Patent Office intends to grant a Patent for Selection Algorithm

NextCell Pharma AB ("NextCell" or the "Company") today announces that the European Patent Office (EPO) has issued an Intention to Grant notice relating to the patent entitled "Allogeneic Composition" (publication number EP3752598). The patent describes the method of manufacturing the drug candidate ProTrans, where the selection algorithm is key for selecting optimal cells and donors.  Patent protection is valid until 2039.The selection algorithm consists of a method for selecting cells with a suitable immunomodulatory effect that are assessed by a panel of different analyses. The algorithm

Abilia acquires Cognita AS

MedCap (publ) has, through its subsidiary Abilia, signed an agreement to acquire the company Cognita AS (“Cognita”). The transaction has an important value to Abilia, that has a leading position in assistive technology in the Nordics, by strengthening and broadening the position within digital assistive products.Cognita has since many years established a strong position in assistive products in Norway. The company’s turnover in 2021 was 15 mNOK with good profitability. Abilia pays 12 mNOK in cash on closing, which is planned for June 1, 2022. The acquisition is expected to have a marginally

ExpreS2ion announces financial results for the first quarter 2022

Hørsholm, Denmark, May 31, 2022 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its first quarter financial results for 2022. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “The quarter started on a strong note, as we were able to present further positive preclinical proof-of-concept results for our HER2-cVLP breast cancer vaccine in the beginning of January and positive proof-of-concept also in a metastatic outgrowth therapeutic tumor mice model here in May which

Rejlers strengthens offering in Sustainable Buildings

There is a great and untapped potential in energy efficiency and renovation of the country's existing property portfolio in the journey towards a fossil-free Sweden. As part of this, Rejlers is now strengthening the offering within Sustainable Buildings with a particular focus on redevelopment and the entire building's life cycle.The construction and real estate sector accounts for about a third of Sweden's energy use and just over a fifth of the country's greenhouse gas emissions, according to the Swedish National Board of Housing, Building and Planning. In connection with new construction,

Hoist Finance acquires NPL portfolio in UK

Hoist Finance has entered into an agreement to acquire a UK portfolio of non-performing loans, comprising of unsecured consumer loans. The total outstanding balance is approximately SEK 2.75 billion. The total investment is approximately SEK 1.0 billion. “We are pleased to announce this acquisition of a major portfolio in the important UK market. The previously announced divestment of our existing UK unsecured portfolio and credit management operations releases capital that we now invest in portfolios with attractive returns. In accordance with our UK strategy, credit management of this

Analysis: Nightingale Health’s net impact among the top 7 percent of companies worldwide

Press release, 31 May 2022 at 9:30 a.m. (EEST) Nightingale Health Plc’s (“Nightingale") positive net impact on the surrounding world has been validated by the Upright Project (“Upright”), a technology company that has developed a quantification model to measure the net impact of companies. Based on Nightingale’s advanced proprietary blood analysis platform technology and innovative solutions in preventative health, the company was awarded a net impact ratio of +70%. The result counts among the best 7% of all companies globally. Publicly listed companies on Nasdaq Helsinki have, on

Raisio to classify its fish feed business as assets held for sale and to report the business as discontinued operations

Stock exchange release 31 May 2022 at 9:30 EET   In March 2022, Raisio plc suspended all exports to Russia, including the exports of Raisioaqua Ltd, which is part of Raisio Group. The exports of Raisioaqua’s products to Russia totalled approximately 65 per cent of Raisioaqua’s net sales in 2021, which has now been lost due to the suspension of exports. In other markets, Raisioaqua’s business will be developed normally and determined measures for replacing the lost net sales and reducing costs are already underway. At the moment, Raisioaqua’s net sales for 2022 are estimated to amount

Wyld Networks’ Interim Report Q1 2022: Strong order intake of SEK 28.3 million in Q1

The company commercially launches Wyld Connect, its satellite IoT module, into the market during the first quarter 2022 and receives purchases orders for SEK 28.3 million.CEO Alastair Williamson: “After launching Wyld Connect in Q1, we have built upon the huge amount of momentum in signing launch partners during the last 12 months and have converted three of these launch partner agreements into purchase orders. Wyld Networks has received purchase orders from a South African Agricultural company with a total value of SEK 17 million for delivery of the Wyld Connect modules over a four-year

Remedy Entertainment Plc applies for listing of option rights 2019

Remedy Entertainment Plc | Stock Exchange Release 9.30 am (EEST) May 31, 2022 Remedy Entertainment Plc applies for listing of option rights 2019 Remedy Entertainment Plc (the “Company”) will apply for the listing of its 2019 option rights on the Nasdaq Helsinki Ltd First North Growth marketplace as of June 1, 2022. A total number of 400,000 option rights 2019 have been issued. Remedy Entertainment Plc has cancelled a total of 29,000 option rights 2019 held by the Company. After the cancellation, the remaining 371,000 option rights 2019 entitle holders to subscribe for 371,000

FluoGuide A/S publishes interim report for the period January – March 2022

Copenhagen, Denmark, 31 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results for the period 1 January – 31 March 2022. The Q1 report is available as an attached document to this press release and on FluoGuide’s website. luFilings & reports - FluoGuide A/S oGuide has ean agreementGuide has ean agreement with the Department of Neurosurgery, Linköping University Hospital, Sweden to become the . [A picture containing background pattern Description automatically generated]   *) Result per share (DKK per

Storebrand Livsforsikring AS: Change in group management

Geir Holmgren has resigned from his position as Managing Director of Storebrand Livsforsikring AS and Executive Vice President of the Storebrand Group to begin as the new CEO of Gjensidige. "Geir is a committed and knowledgeable leader with broad professional experience. I want to thank Geir for all the good collaboration and the results he has achieved over the past 25 years in Storebrand. I wish Geir all the best of luck in a very exciting new job for him", says CEO of Storebrand ASA, Odd Arild Grefstad. Holmgren will leave his position in Storebrand on Friday the 3rd of June.

STOREBRAND ASA: Change in group management

Geir Holmgren has resigned from his position as Managing Director of Storebrand Livsforsikring AS and Executive Vice President of the Storebrand Group to begin as the new CEO of Gjensidige. "Geir is a committed and knowledgeable leader with broad professional experience. I want to thank Geir for all the good collaboration and the results he has achieved over the past 25 years in Storebrand. I wish Geir all the best of luck in a very exciting new job for him", says CEO of Storebrand ASA, Odd Arild Grefstad. Holmgren will leave his position in Storebrand on Friday the 3rd of June.

Geir Holmgren appointed as new CEO in Gjensidige. Invitation to webcast

The Board of Directors in Gjensidige Forsikring ASA has appointed Geir Holmgren as new Chief Executive Officer (CEO) in Gjensidige. He will succeed Helge Leiro Baastad who has led the Group since 2003. Holmgren will assume the position on 2 January 2023.Helge Leiro Baastad will retire from the position in accordance with his employment contract. He will continue to hold the role of CEO until Geir Holmgren joins Gjensidige. · Helge Leiro Baastad has led Gjensidige through substantial changes. From being a part of Gjensidige NOR to becoming a solid and profitable listed company. He has

Alligator Bioscience to Present Additional data of ATOR-1017 First-in-Human Study via poster presentation at ASCO Annual Meeting 2022

· ATOR-1017 demonstrates an excellent clinical profile as a potential best-in-class 4-1BB monoclonal antibody · ATOR-1017 was safe and well tolerated at doses up to 600 mg · No dose-limiting toxicity was observed and maximum tolerated dose was not reached · Stable disease was achieved in 45% of patients with solid tumors · Dose escalation continues at 900 mg dose level Lund, Sweden, May 31, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces it will present a poster on the 4-1BB conditional agonist antibody ATOR-1017 at the 2022 ASCO (American Society of

Change in number of shares and votes in Boliden

As previously announced, the annual general meeting in Boliden on April 28, 2022 resolved on an automatic share redemption procedure including a split of Boliden’s shares, a so called share split 2:1, whereby one existing share is divided into two shares. The share split has been carried out during May 2022, resulting in an increase of the number of shares and votes in Boliden by 273,511,169. As of May 31, 2022 the number of shares and votes in Boliden totals 547,022,338. The shares added through the share split will, however, be redeemed during June 2022 as a part of the redemption

Capitainer raises additional SEK34 million to meet the increasing demand for home-sampling solutions

Stockholm, May 31, 2022: Swedish medtech start-up Capitainer today announced that it has closed a share issue of SEK34 million to capitalise on growing interest in home-sampling with its new qDBS dried blood spot testing system. The investment round, led by Sciety, brought in both existing and new industry specialist investors and several board members and the CEO.Ernst Westman, Capitainer Chairman commented: “Once again we are delighted to have secured such strong support from experienced medtech and diagnostics industry investors. COVID-19 presented us with an unexpected obstacle, but

New number of shares and votes in Fastighets AB Balder (publ)

The share split resolved by the 2022 Annual General Meeting has now been implemented, after which the number of shares and votes in Fastighets AB Balder (publ) (“Balder”) has changed. The total number of shares in Balder as of May 31 2022, the last trading day of the month, amounts to 1,119,000,000, of which 67,376,592 class A shares and 1,051,623,408 class B shares, corresponding to a total of 172,538,932.8 votes. For further information, please contact:Erik Selin, CEO, tel. +46 (0)31-10 95 92Eva Sigurgeirsdottir, Director of Economy, tel. +46 (0)31-10 99 13 This information

New number of shares and votes in BioGaia AB (publ)

The number of shares and votes in BioGaia has increased during May due to the share split resolved by BioGaia’s Annual General Meeting on 6 May 2022, whereby each existing share, regardless of series, was divided into five new shares. As of 31 May 2022, the total number of shares in BioGaia amounts to 100,982,310 (previously 20,196,462 shares), whereof 3,703,340 A shares, with ten votes each, and 97,278,970 B shares, with one vote each, corresponding to in total 134,312,370 votes. The share capital is unchanged and amounts to SEK 20,196,462. As of 31 May 2022, BioGaia holds no

Guide to10 New things to do in Bangkok

Bangkok is one of Thailand’s most vibrant cities. You will never get dull in the city that never sleeps. After the awakening of the pandemic, Bangkok came back to life with so many new things happening. This is definitely one of the reasons why Bangkok retains “The Best City” according to DestinAsian magazine’s 2022 Readers’ Choice Awards. Photo Credit: Anders Pihl  Travelers are familiar with major tourist attractions in Bangkok including historical or religious sites such as Wat Phra Sri Rattana Satsadaram (Phra Kaew), Wat Pho, Temple of dawn (Wat Arun),Grand palace and

Key personnel at the Byggmax Group acquire warrants

Key personnel at the Byggmax Group acquire 500,000 warrants under the recently decided 2022/2027 incentive program. The Annual General Meeting on May 5, 2022 resolved in favor of an incentive program, comprising a private placement of warrants to the subsidiary, Byggmax AB, for onward assignment at market value to key individuals at the Byggmax Group. Each warrant entitles the holder, during the period June 14, 2027 through December 13, 2027, to subscribe for one (1) new share in Byggmax Group AB at a subscription price of SEK 82. The resolution means that twelve key individuals at the

Change in the number of shares and votes in Humana AB

As previously communicated , the Annual General Meeting decided on May 10, 2022, to redeem 5,314,006 own shares that had been repurchased through previous repurchase authorisations, and to increase share capital through a bonus issue. After the redemption, as of May 31, 2022, the total number of shares and votes, in Humana AB amounts to 47,826,058. For more information, please contact:Noora Jayasekara, CFO, +46 70 318 92 97, noora.jayasekara@

There are no items matching the current filter
There are no more items matching the current filter
Back to top